Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Chronic respiratory diseases are the third leading cause of death, behind cardiovascular diseases and cancer, affecting approximately 550 million of people all over the world. Most of the chronic respiratory diseases are attributable to asthma and chronic obstructive pulmonary disease (COPD) with th...
Saved in:
Main Authors: | Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova, Mirco Govoni |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/622a70fbc2e348a4a103a94d0a8020b0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphodiesterase-4 Inhibition in Psoriasis
by: Milakovic M, et al.
Published: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
by: Priyadarshini Kachroo, et al.
Published: (2021) -
The Involvement of PDE4 in the Protective Effects of Melatonin on Cigarette-Smoke-Induced Chronic Obstructive Pulmonary Disease
by: Je-Oh Lim, et al.
Published: (2021) -
Lung Health in the Solomon Islands: A Mixed Methods Study
by: Di Michiel J, et al.
Published: (2021) -
The Role of PDE11A4 in Social Isolation-Induced Changes in Intracellular Signaling and Neuroinflammation
by: Katy Pilarzyk, et al.
Published: (2021)